A bill for an act relating to insurance coverage for supplemental and diagnostic breast examinations.(See SF 2358.)
Impact
The provisions of SSB3135 will specifically apply to various types of insurance policies delivered, issued for delivery, or renewed in the state beginning January 1, 2025. This includes individual and group accident and sickness insurance, hospital or medical service contracts, and health maintenance organization contracts. By requiring coverage for supplemental and diagnostic breast examinations, the bill aims to improve early detection and treatment options for breast cancer, which could potentially increase public health outcomes related to breast cancer awareness and management.
Summary
Senate Study Bill 3135 (SSB3135) proposes new requirements for insurance coverage pertaining to supplemental and diagnostic breast examinations. The bill mandates that insurance policies providing third-party payment or prepayment for health or medical expenses include coverage for such examinations. This coverage must be at least as favorable as that provided for screening mammograms, ensuring that patients have access to essential diagnostic tools without financial burden from cost-sharing requirements.
Contention
While the bill primarily focuses on enhancing healthcare access, potential contention may arise regarding the implications for insurance carriers in terms of compliance and the financial impact of mandated coverage on premium costs. Some stakeholders may argue that these requirements could lead to higher costs for health insurers, which may subsequently be passed on to consumers through increased premiums. Additionally, discussions might center around how this aligns with broader healthcare costs and insurance reform efforts in the state.